References
- Privor-Dumm LA, Poland GA, Barratt J, et al. A global agenda for older adult immunization in the COVID-19 era: a roadmap for action. Vaccine. 2021;39(37):5240–5250. doi:10.1016/j.vaccine.2020.06.082
- Wagner A, Weinberger B. Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives. Front Immunol. 2020;11:717.
- Sachet G, Hardesty C, Aizan T, et al. The decade of healthy ageing in ASEAN: role of life-course immunisation; 2021. Available from: https://www.eu-asean.eu/wp-content/uploads/2022/02/The-Decade-of-Healthy-Ageing-in-ASEAN-Role-of-Life-course-Immunisation-2021.pdf. Accessed October 20, 2022.
- Litt J, Booy R, Bourke D, et al. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine. Hum Vaccin Immunother. 2020;16(12):3081–3089. doi:10.1080/21645515.2020.1754702
- Seth A, Pangestu T. Promoting older adults immunization: a pathway to healthy aging in the Asia Pacific; 2021. Available from: https://medicine.nus.edu.sg/apic/wp-content/uploads/sites/28/2022/06/APIC_Policy_Brief_Life_Course_Immunisation_Final_June-2022-1.pdf. Accessed October 20, 2022.
- Jiang X, Shang X, Lin J, Zhao Y, Wang W, Qiu Y. Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: a quasi-experimental study. Vaccine. 2021;39(5):846–852. doi:10.1016/j.vaccine.2020.12.040
- Bai X, Chen L, Liu X, et al. Adult hepatitis B virus vaccination coverage in China from 2011 to 2021: a systematic review. Vaccines. 2022;10(6). doi:10.3390/vaccines10060900
- Verma R, Khanna P, Chawla S. Vaccines for the elderly need to be introduced into the immunization program in India. Hum Vaccin Immunother. 2014;10(8):2468–2470. doi:10.4161/hv.29254
- Vora A, Di Pasquale A, Kolhapure S, Agrawal A. Vaccination in older adults: an underutilized opportunity to promote healthy aging in India. Drugs Aging. 2021;38(6):469–479. doi:10.1007/s40266-021-00864-4
- Cowling BJ, Caini S, Chotpitayasunondh T, et al. Influenza in the Asia-Pacific region: findings and recommendations from the Global Influenza Initiative. Vaccine. 2017;35(6):856–864. doi:10.1016/j.vaccine.2016.12.064
- Owusu JT, Prapasiri P, Ditsungnoen D, et al. Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010–2012. Vaccine. 2015;33(5):742–747. doi:10.1016/j.vaccine.2014.10.029
- Menzies R, Stein AN, Booy R, Van Buynder PG, Litt J, Cripps AW. The impact of the changing pneumococcal national immunisation program among older Australians. Vaccine. 2021;39(4):720–728. doi:10.1016/j.vaccine.2020.12.025
- Chen Q, Wang L, Xie M, Li X; Recommendations for Influenza SpViEPiCWGGRG, Chinese Society of G. Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China. Aging Med. 2020;3(1):4–14. doi:10.1002/agm2.12102
- Hou Z, Guo J, Lai X, et al. Influenza vaccination hesitancy and its determinants among elderly in China: a national cross-sectional study. Vaccine. 2022;40(33):4806–4815. doi:10.1016/j.vaccine.2022.06.063
- Krishnan A, Dar L, Amarchand R, et al. Cohort profile: Indian Network of Population-based surveillance platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE). BMJ Open. 2021;11(10):e052473. doi:10.1136/bmjopen-2021-052473
- Dash R, Agrawal A, Nagvekar V, et al. Towards adult vaccination in India: a narrative literature review. Hum Vaccin Immunother. 2020;16(4):991–1001. doi:10.1080/21645515.2019.1682842
- Zahra. The availability of vaccines in Indonesia is adequate, but the availability of cold chain infrastructure facilities is still experiencing obstacles; 2021. Available from: https://feb.ugm.ac.id/en/news/3494-The-availability-of-vaccines-in-indonesia-is-adequate-but-The-availability-of-cold-chain-infrastructure-facilities-is-still-experiencing-obstacles. Accessed October 20, 2022.
- Utami A, Margawati A, Pramono D, Nugraheni A, Pramudo SG. Determinant factors of COVID-19 vaccine hesitancy among adult and elderly population in Central Java, Indonesia. Patient Prefer Adherence. 2022;16:1559–1570. doi:10.2147/PPA.S365663
- Vaccinations; 2021. Available from: http://japanhpn.org/en/vaccinations-2/. Accessed October 20, 2022.
- Wong LP, Wong PF, AbuBakar S. Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country. Hum Vaccin Immunother. 2020;16(7):1511–1520. doi:10.1080/21645515.2019.1706935
- Cruz GT, Laguna EP, Paguirigan MRB, et al. Vaccinating the most vulnerable group in the time of pandemic: insights from a national survey of older people (UPPI/DRDF Research Brief No. 9); 2021. Available from: https://www.uppi.upd.edu.ph/research/covid-19/rb9. Accessed October 20, 2022.
- Amit AML, Pepito VCF, Sumpaico-Tanchanco L, Dayrit MM. COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines. PLOS Glob Public Health. 2022;2(1):e0000165. doi:10.1371/journal.pgph.0000165
- Nguyen MH, Li Chen L, Lim KW, Chang WT, Mamun K. Vaccination in older adults in Singapore: a summary of recent literature. Proceed Singapore Healthc. 2015;24(2):94–102. doi:10.1177/201010581502400205
- Yang TU, Kim E, Park Y-J, et al. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure. Vaccine. 2016;34(13):1623–1629. doi:10.1016/j.vaccine.2016.01.043
- Chen CH, Wu MS, Wu IC. Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan: a nation-wide community-based study. Medicine. 2018;97(5):e9773. doi:10.1097/MD.0000000000009773
- Nicholls LAB, Gallant AJ, Cogan N, Rasmussen S, Young D, Williams L. Older adults’ vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. Vaccine. 2021;39(26):3520–3527. doi:10.1016/j.vaccine.2021.04.062
- Govaert TME, Thijs CT, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661–1665. doi:10.1001/jama.1994.03520210045030
- Raina MacIntyre C, Menzies R, Kpozehouen E, et al. Equity in disease prevention: vaccines for the older adults – a national workshop, Australia 2014. Vaccine. 2016;34(46):5463–5469. doi:10.1016/j.vaccine.2016.09.039
- Woodward M. Immunisation of older people. J Pharm Pract Res. 2012;42(4):316–322. doi:10.1002/j.2055-2335.2012.tb00197.x
- Dhama K, Sharun K, Tiwari R, et al. COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother. 2021;17(10):3495–3499. doi:10.1080/21645515.2021.1926183
- Hosoda M. Vaccine hesitancy in Japan: from a perspective on medical uncertainty and trans-scientific theory [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research. 2023;11(1103):1103. doi:10.12688/f1000research.125159.2
- Harapan H, Anwar S, Yufika A, et al. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog Glob Health. 2022;116(4):236–243. doi:10.1080/20477724.2021.2011580
- Razai MS, Osama T, McKechnie DGJ, Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ. 2021;372:n513. doi:10.1136/bmj.n513
- Garcia LL, Yap JFC. The role of religiosity in COVID-19 vaccine hesitancy. J Public Health. 2021;43(3):e529–e30. doi:10.1093/pubmed/fdab192
- Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160. doi:10.3390/vaccines9020160
- Vaccine apathy: status, challenges, and prospects; 2022. Available from: https://www.frontiersin.org/research-topics/41534/vaccine-apathy-status-challenges-and-prospects#overview. Accessed October 20, 2022.
- Barratt DJ, Beckett MR, Acton MM, Sebastian MS, Nguyen MW. Adult Vaccination in the Asia Pacific: mobilizing policy and practice knowledge; 2019. Available from: https://ifa.ngo/wp-content/uploads/2019/10/Adult-Vaccination-in-The-Asia-Pacific-%E2%80%93-Mobilizing-Policy-and-Practice-Knowledge.pdf. Accessed October 20, 2022.
- Matsui D, Shigeta M, Ozasa K, Kuriyama N, Watanabe I, Watanabe Y. Factors associated with influenza vaccination status of residents of a rural community in Japan. BMC Public Health. 2011;11(1):149. doi:10.1186/1471-2458-11-149
- Liu S, Xu E, Liu Y, et al. Factors associated with pneumococcal vaccination among an urban elderly population in China. Hum Vaccin Immunother. 2014;10(10):2994–2999. doi:10.4161/21645515.2014.972155
- Jiang M, Li P, Yao X, et al. Preference of influenza vaccination among the elderly population in Shaanxi province, China. Hum Vaccin Immunother. 2021;17(9):3119–3125. doi:10.1080/21645515.2021.1913029
- Melo A, de Macêdo LS, Invenção M, et al. Third-generation vaccines: features of nucleic acid vaccines and strategies to improve their efficiency. Genes. 2022;13(12):2287. doi:10.3390/genes13122287
- Skibinski DA, Baudner BC, Singh M, O’Hagan DT. Combination vaccines. J Glob Infect Dis. 2011;3(1):63–72. doi:10.4103/0974-777X.77298
- Paguio JA, Yao JS, Dee EC. Silver lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study. Vaccine. 2020;38(34):5430–5435. doi:10.1016/j.vaccine.2020.06.069
- Gong L, Zhang X, Qu Z, et al. Public interest in distribution and determinants of influenza and pneumonia vaccination during the COVID-19 pandemic: an infodemiology and cross-sectional study from China. Vaccines. 2021;9:1329. doi:10.3390/vaccines9111329
- Zhou M, Zhan J, Kong N, Campy KS, Chen Y. Factors associated with intention to uptake pneumococcal vaccines among Chinese elderly aged 60 years and older during the early stage of COVID-19 pandemic. Psychol Health Med. 2022;27(1):91–105. doi:10.1080/13548506.2021.1905862
- Zaini K, Ha HT. Understanding the selective hesitancy towards Chinese vaccines in Southeast Asia; 2021. Available from: https://www.iseas.edu.sg/articles-commentaries/iseas-perspective/2021-115-understanding-The-selective-hesitancy-towards-chinese-vaccines-in-southeast-asia-by-khairulanwar-zaini-and-hoang-thi-ha/. Accessed October 20, 2022.
- Thanapluetiwong S, Chansirikarnjana S, Sriwannopas O, Assavapokee T, Ittasakul P. Factors associated with COVID-19 vaccine hesitancy in Thai seniors. Patient Prefer Adherence. 2021;15:2389–2403. doi:10.2147/PPA.S334757
- Singapore’s older adults resist COVID-19 vaccinations; 2021. Available from: https://news.smu.edu.sg/news/2021/07/06/singapores-older-adults-resist-covid-19-vaccinations. Accessed October 20, 2022.
- Ang LW, Cutter J, James L, Goh KT. Factors associated with influenza vaccine uptake in older adults living in the community in Singapore. Epidemiol Infect. 2017;145(4):775–786. doi:10.1017/S0950268816002491
- Moosa AS, Wee YMS, Jaw MH, et al. A multidisciplinary effort to increase COVID-19 vaccination among the older adults. Front Public Health. 2022;10:904161. doi:10.3389/fpubh.2022.904161
- Tsai TF, Rao RD, Xu ZY. 75 - immunization in the Asia-Pacific region. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin’s Vaccines. Seventh ed. Elsevier; 2018:1466–85.e2.